|
|
Volumn 706, Issue 2, 1998, Pages 287-294
|
|
Quantitative analytical methods for the determination of a new hypertension drug, CGS 25462, and its metabolites (CGS 25659 and CGS 24592) in human plasma by high-performance liquid chromatography
a
|
|
Author keywords
CGS 24592; CGS 25462; CGS 25659
|
|
Indexed keywords
3 [N [2 [[(DIPHENYLPHOSPHONO)METHYL]AMINO] 3 (4 BIPHENYLYL)PROPIONYL]AMINO]PROPIONIC ACID;
ANTIHYPERTENSIVE AGENT;
CGS 24592;
CGS 25659;
DRUG METABOLITE;
UNCLASSIFIED DRUG;
ACCURACY;
ADULT;
ARTICLE;
CALIBRATION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG MONITORING;
FLUORESCENCE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
HUMAN TISSUE;
LIQUID LIQUID EXTRACTION;
MALE;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REPRODUCIBILITY;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
TECHNIQUE;
ULTRAVIOLET SPECTROPHOTOMETRY;
ADMINISTRATION, ORAL;
ANTIHYPERTENSIVE AGENTS;
BIPHENYL COMPOUNDS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CIRCADIAN RHYTHM;
HALF-LIFE;
HUMANS;
MALE;
PHENYLALANINE;
PHOSPHONIC ACIDS;
PRODRUGS;
PROTEASE INHIBITORS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
TEMPERATURE;
TIME FACTORS;
|
|
EID: 0032549608
PISSN: 15726495
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(97)00566-5 Document Type: Article |
|
Times cited : (5)
|
|
References (2)
|
